Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/24/2025

Management of Pseudogout with Corticosteroids

  • The American College of Rheumatology guidelines provide Level A evidence supporting oral corticosteroids for crystal arthropathy, with a recommended starting dose of 30-35 mg prednisone daily for 5 days 1
  • An alternative approach is 2-5 days at full dose, then taper over 7-10 days, as suggested by the Arthritis Care & Research journal 2, 1

Alternative Corticosteroid Routes for Pseudogout

  • For monoarticular involvement of 1-2 large joints, consider intra-articular corticosteroid injection, with dose varying by joint size 2, 1

Clinical Decision Algorithm

  • The American College of Rheumatology guidelines recommend assessing contraindications to corticosteroids, including systemic fungal infections, uncontrolled diabetes, active peptic ulcer disease, and immunocompromised state 1
  • For polyarticular or multiple small joints, oral prednisone 30-35 mg daily is recommended 1

Important Caveats and Pitfalls

  • Low-dose prednisone for CPPD prophylaxis should be ≤10 mg/day, not the 30-35 mg used for acute flares, as recommended by the Arthritis Care & Research journal 4, 5, 1
  • A 5-10 day course of corticosteroids carries minimal risk, with adverse effects limited to dysphoria, mood changes, elevated glucose, and fluid retention 1, 3
  • Corticosteroids are generally safer and lower cost compared to alternatives like IL-1 inhibitors, making them first-line therapy when NSAIDs are contraindicated 1